These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7798126)

  • 21. Severe persistent visual field constriction associated with vigabatrin. Benefit: risk ratio must be calculated for individual patients.
    Harding GF
    BMJ; 1998 Jan; 316(7126):232-3. PubMed ID: 9468716
    [No Abstract]   [Full Text] [Related]  

  • 22. [Subsequent manic disorder due to combination vigabatrin-clomipramine].
    Sastre-Garau P; Thomas P; Beaussart M; Goudemand M
    Encephale; 1994; 20(3):363. PubMed ID: 8088239
    [No Abstract]   [Full Text] [Related]  

  • 23. Acute pancreatitis associated with dual vigabatrin and lamotrigine therapy.
    Jadresic D
    Seizure; 1994 Dec; 3(4):319. PubMed ID: 7534594
    [No Abstract]   [Full Text] [Related]  

  • 24. Disturbed metabolism of guanidino compounds characterized by elevated excretion of beta-guanidinopropionic acid and gamma-guanidinobutyric acid--an effect of vigabatrin treatment?
    Schulze A; Mayatepek E; Frank S; Marescau B; De Deyn PP; Bachert P
    J Inherit Metab Dis; 1998 Jun; 21(3):268-71. PubMed ID: 9686372
    [No Abstract]   [Full Text] [Related]  

  • 25. [Acute psychosis and vigabatrin in childhood].
    Chiaretti A; Castorina M; Tortorolo L; Piastra M; Polidori G
    Pediatr Med Chir; 1994; 16(5):489-90. PubMed ID: 7885961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infantile spasms and vigabatrin. Visual field defects may be permanent.
    Lhatoo SD; Sander JW
    BMJ; 1999 Jan; 318(7175):57. PubMed ID: 10068225
    [No Abstract]   [Full Text] [Related]  

  • 27. Obstructive sleep apnoea following rapid weight gain secondary to treatment with vigabatrin (Sabril).
    Lambert MV; Bird JM
    Seizure; 1997 Jun; 6(3):233-5. PubMed ID: 9203253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe persistent visual field constriction associated with vigabatrin. Chronic refractory epilepsy may have role in causing these unusual lesions.
    Wilson EA; Brodie MJ
    BMJ; 1997 Jun; 314(7095):1693. PubMed ID: 9193311
    [No Abstract]   [Full Text] [Related]  

  • 29. Electrophysiologic evaluation of a patient with peripheral visual field contraction associated with vigabatrin.
    Ruether K; Pung T; Kellner U; Schmitz B; Hartmann C; Seeliger M
    Arch Ophthalmol; 1998 Jun; 116(6):817-9. PubMed ID: 9639460
    [No Abstract]   [Full Text] [Related]  

  • 30. Reversibility of vigabratin-induced visual-field defect.
    Versino M; Veggiotti P
    Lancet; 1999 Aug; 354(9177):486. PubMed ID: 10465180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Vigabatrin--a new antiepileptic agent].
    Nakken KO; Henriksen O; Johannessen SI
    Tidsskr Nor Laegeforen; 1994 Oct; 114(24):2843-4. PubMed ID: 7998031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The irreversible gamma-aminobutyrate transaminase inhibitor vigabatrin in the treatment of the alcohol withdrawal syndrome.
    Stuppaeck CH; Deisenhammer EA; Kurz M; Whitworth AB; Hinterhuber H
    Alcohol Alcohol; 1996 Jan; 31(1):109-11. PubMed ID: 8672169
    [No Abstract]   [Full Text] [Related]  

  • 33. Vigabatrin aggravates absences and absence status.
    Cocito L; Primavera A
    Neurology; 1998 Nov; 51(5):1519-20. PubMed ID: 9818915
    [No Abstract]   [Full Text] [Related]  

  • 34. Inappropriate use of carbamazepine and vigabatrin in typical absence seizures.
    Parker AP; Agathonikou A; Robinson RO; Panayiotopoulos CP
    Dev Med Child Neurol; 1998 Aug; 40(8):517-9. PubMed ID: 9746003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse effects of vigabatrin in Angelman syndrome.
    Kuenzle C; Steinlin M; Wohlrab G; Boltshauser E; Schmitt B
    Epilepsia; 1998 Nov; 39(11):1213-5. PubMed ID: 9821987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vigabatrin-associated reversible acute psychosis in a child.
    Cánovas Martínez A; Ordovás Baines JP; Beltrán Marqués M; Escrivá Aparisi A; Delgado Cordón F
    Ann Pharmacother; 1995 Nov; 29(11):1115-7. PubMed ID: 8573955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aggravation of focal epileptic seizures by antiepileptic drugs.
    Elger CE; Bauer J; Scherrmann J; Widman G
    Epilepsia; 1998; 39 Suppl 3():S15-8. PubMed ID: 9593231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New antiepileptic drugs: vagabatrin, lamotrigine and felbamate].
    Herranz JL; Arteaga R; Armijo JA
    Neurologia; 1994 Nov; 9(9):410-7. PubMed ID: 7811493
    [No Abstract]   [Full Text] [Related]  

  • 39. Vigabatrin in unsatisfactory controlled epilepsies. Swiss Vigabatrin Study Group.
    Russ W
    Schweiz Arch Neurol Psychiatr (1985); 1995; 146(2):55-9. PubMed ID: 7569836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outer retinal dysfunction in patients treated with vigabatrin.
    Arndt CF; Derambure P; Defoort-Dhellemmes S; Hache JC
    Neurology; 1999 Apr; 52(6):1201-5. PubMed ID: 10214744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.